FindTrial
Sign In

To study the effect of Jeerakadi lepa and manjistha lepa in vyangya with reference to melasma

Randomized Comparative Clinical Study to evaluate the efficacy of Jeerakadi lepa and Manjistha lepa in the Management of Vyangya w.s.r to Melasma - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078478
Enrollment
80
Registered
2024-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Sponsors

Dr VJD Gramin Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having clinical features of Vyanga. 2.Patients willing to sign the informed consent form. 3.Patient of either gender, irrespective of socioeconomic status. 4.Patients not using any topical treatment for melasma prior to enrollement in study.

Exclusion criteria

Exclusion criteria: 1.Patients taking O.C.Pills. 2.Patients suffering from other skin disorder and other systemic disorder. 3.Patients associated with any serious systemic disorders. 4.History of Allergy to topical application. 5.Cancer of skin.

Design outcomes

Primary

MeasureTime frame
Symptoms of Vyangya like 1. Black spot 2.Brown spot 3.itching All the above symptoms Will be decreased and control over Vyangya with reference to 2.melasmaTimepoint: 7,14,21,28 Days Symptoms will be Observed—

Secondary

MeasureTime frame
Decreased in symptoms of Vyangya & hyperpigmmantion Like darkness black spotTimepoint: 18 month—

Countries

India

Contacts

Public ContactDr Vikram Singh chavan

Dr VJD Gramin ayurved mahavidyalaya patur

tinavikramsing2006@gmail.com8275730257

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026